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Abstract
Background: Human dental mesenchymal stem cells (MSCs) are considered as highly accessible and attractive
MSCs for use in regenerative medicine, yet some of their features are not as well characterized as other MSCs.
Hypoxia-preconditioning and hypoxia-inducible factor 1 (HIF-1) alpha overexpression significantly improves MSC
therapeutics, but the mechanisms involved are not fully understood. In the present study, we characterize
immunomodulatory properties of dental MSCs and determine changes in their ability to modulate adaptive and
innate immune populations after HIF-1 alpha overexpression.
Methods: Human dental MSCs were stably transduced with green fluorescent protein (GFP-MSCs) or GFP-HIF-1
alpha lentivirus vectors (HIF-MSCs). A hypoxic-like metabolic profile was confirmed by mitochondrial and glycolysis
stress test. Capacity of HIF-MSCs to modulate T-cell activation, dendritic cell differentiation, monocyte migration,
and polarizations towards macrophages and natural killer (NK) cell lytic activity was assessed by a number of
functional assays in co-cultures. The expression of relevant factors were determined by polymerase chain reaction
(PCR) analysis and enzyme-linked immunosorbent assay (ELISA).
Results: While HIF-1 alpha overexpression did not modify the inhibition of T-cell activation by MSCs, HIF-MSCs
impaired dendritic cell differentiation more efficiently. In addition, HIF-MSCs showed a tendency to induce higher
attraction of monocytes, which differentiate into suppressor macrophages, and exhibited enhanced resistance to NK
cell-mediated lysis, which supports the improved therapeutic capacity of HIF-MSCs. HIF-MSCs also displayed a
pro-angiogenic profile characterized by increased expression of CXCL12/SDF1 and CCL5/RANTES and complete loss
of CXCL10/IP10 transcription.
Conclusions: Immunomodulation and expression of trophic factors by dental MSCs make them perfect candidates for
cell therapy. Overexpression of HIF-1 alpha enhances these features and increases their resistance to allogenic NK cell
lysis and, hence, their potential in vivo lifespan. Our results further support the use of HIF-1 alpha-expressing dental
MSCs for cell therapy in tissue injury and immune disorders.
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Background
Among different sources of mesenchymal stem cells
(MSCs), dental MSCs (dental pulp, periodontal ligament,
apical papilla, dental follicle, and gingival tissue) are cur-
rently considered as one of the most attractive MSCs for
use in engineering tissue and regenerative medicine.
Great advantages presented by dental MSCs include ac-
cessibility, easy in vitro expansion, low immunogenicity,
and the ability to differentiate into mesoderm-derived
tissues [1]. A low frequency of in vivo differentiation of
transplanted MSCs in experimental models [2–5] indi-
cates that MSCs promote tissue repair through paracrine
modulation of surrounding cells. Cell populations nor-
mally targeted by MSCs include resident progenitor
cells, endothelial cells, and immune cells [6].
Many efforts are currently focused on furthering the
therapeutic potential of MSCs. In this regard, we and
others have previously demonstrated that hypoxia and,
more specifically, overexpression of hypoxia-inducible
factor-1 (HIF-1) by genetic engineering potentiates the
therapeutic properties of MSCs [7]. Owing to the critical
role that the immune response plays in most of the
pathologies targeted by MSC therapy, a better under-
standing of the effects of hypoxia on the immunomodu-
latory capacity of MSCs is of great importance.
In the present study, we present a comprehensive
characterization of the in vitro immunomodulatory
properties and expression of immune and trophic factors
in dental MSCs. Furthermore, we demonstrate that over-
expression of HIF-1 alpha improves several of these fea-
tures, also enhancing their resistance to natural killer
(NK) cell lytic activity.
Methods
All procedures were approved by the Instituto de Salud
Carlos III and Institutional Ethical and Animal Care
Committees.
Vector production, lentiviral transduction, and MSC culture
MSCs from human dental pulp were expanded as de-
scribed previously [8] and transduced with lentiviral vec-
tors pWP-green fluorescent protein (GFP-MSCs) or
pWP-HIF-GFP (HIF-MSCs) as previously described [7].
Transduction efficiency was evaluated by flow cytometry
(Coulter EPICS XL flow cytometer; Beckman Coulter) to
determine the percentage of GFP-positive cells. The per-
centages of infection obtained were normally around
90%. Human dental pulp MSCs (n = 3; Inbiobank) were
cultured in Dulbecco’s modified Eagle’s medium
(DMEM) low glucose (Sigma-Aldrich, Spain) supple-
mented with 10% heat-inactivated fetal calf serum (FCS;
Gibco, Life Technologies, Thermo Fisher Scientific).
Cells were grown until confluence and subsequently
subcultured up to 12 passages. For stimulation assays,
5 × 104 MSCs were seeded in six-well flat-bottom culture
plates and, after 3 days, media were replenished and sup-
plemented or not with 10 ng/ml recombinant human
interferon (rhIFN)-gamma (Invitrogen). After 15 h, cells
were lysed for subsequent analysis by quantitative poly-
merase chain reaction (qPCR).
Seahorse extracellular metabolic-flux assays
The Seahorse extracellular flux analyzer XFp (Seahorse
Bioscience) was used to perform the mitochondrial and
glycolysis stress tests. Detailed conditions are given in
Additional file 1. In both assays, total protein per well
was quantified with the BCA Protein Assay Kit for
normalization.
Mitochondrial stress test
Four basal oxygen consumption rate (OCR) measure-
ments were taken. Subsequently, mitochondrial mem-
brane modulators oligomycin (1 μM), followed by
carbonyl cyanide p-trifluoromethoxy-phenylhydrazone
(FCCP; 1 μM) and finally antimycin A/rotenone (both
1 μM) were injected (four measuring cycles each). Basal
respiration, ATP production, maximal respiration, spare
respiratory capacity, and proton leak were defined by the
differences between the average measurements 4–16, 4–8,
12–16, 4–9, and 8–16, respectively. Non-mitochondrial
respiration was defined by the average measurement 16.
Glycolysis stress test
Extracellular acidification rate (ECAR) measurements
were taken. Subsequently, glucose (10 mM), followed by
oligomycin (1 μM) and 2-deoxy-glucose (2-DG; 100 mM)
were injected (four measuring cycles each). Basal glycoly-
sis, glycolytic capacity, and glycolytic reserve were
calculated by the differences between the average
measurements 4–8, 12–16, and 8–12, respectively. Non-
glycolytic acidification was defined by the average meas-
urement 16.
Microarray assays
Human MSCs from dental pulp cultured under
normoxia, hypoxia, and lentivirally transduced with
GFP-HIF-1 alpha or GFP empty vector (n = 3 different
donors) were collected and 800 ng total RNA was ex-
tracted. RNA purity and concentration were evaluated
spectrophotometrically using a NanoDrop ND-2000
(ThermoFisher). A260/230 and A260/280 ratios were
mainly used, but the full spectra were reviewed to assess
the presence of contaminants: peptides, phenols, aro-
matic compounds, or carbohydrates, and proteins. The
quality and integrity of total RNA from the cell cultures
were assessed by a microfluidics-based platform Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara)
with the Agilent RNA 6000 Nano Kit for RIN
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calculation. Electropherograms were visualized with the
Agilent 2100 Expert software including data collection,
peak detection, and interpretation of the different profiles.
RNA expression levels were measured by microarrays.
All control and sample RNAs tested were selected
according to integrity criteria. Expression profile was
determined using the PrimeView Affymetrix platform
including all annotated genes based in the NCBI Human
Genome version 37 (GRCh37). This version contains
48,658 probe sets including 419 UniGene probe sets not
covered by RefSeq probe sets.
Total RNA (250 ng) was retrotranscribed to cDNA
from polyA tail, double-stranded and transcribed into
cRNA. Labeling and fragmentation of this cRNA was
performed following the manufacturer’s procedures. The
GeneChip® Scanner 3000 7G System and reagents from
Affymetrix were used to hybridize, wash, stain, and scan
the arrays. Hybridization was performed by the micro-
array core facility from IIS La Fe.
Microarray data analysis
Differential gene expression was measured using fold-
change. Results were considered to be significant with a
1.5-fold induction. Gene ontology (GO) analysis was car-
ried out with the Consensuspathdb software tool (http://
cpdb.molgen.mpg.de/) [9] and used to identify the bio-
logical pathways associated with the mRNAs differen-
tially expressed in HIF-MSCs vs GFP-MSCs, and in
MSC cultured under hypoxia versus normoxia condi-
tions for comparison.
Isolation and culture of human blood cells
Buffy coats of healthy donors were obtained after in-
formed consent (Centro de Transfusión de la Comunidad
de Madrid, Spain) and peripheral blood mononuclear cells
(PBMCs) were isolated by density gradient centrifugation
with Lymphocyte Isolation Solution (Rafer). Monocytes
and NK cells were isolated by positive and negative
magnetic separation (MiltenyiBiotec). Non-adherent T
lymphocyte-enriched cell suspensions were obtained by
nylon wool purification. The percentage of CD3+ cells was
always above 85%.
CD14+ cells (5 × 105) were cultured in six-well flat-
bottom culture plates for 6 days in 50% DMEM/10%
FCS and 50% complete medium, consisting of RPMI
(Lonza) supplemented with 10% FCS, 1 mM pyruvate,
2 mM glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin (all from Sigma-Aldrich, Spain), plus
20 ng/ml recombinant human granulocyte macrophage-
colony stimulating factor (rhGM-CSF) and 20 ng/ml re-
combinant human interleukin (rhIL)-4 (Invitrogen) to
generate immature monocyte-derived dendritic cells
(MoDCs), or 5 ng/ml rhGM-CSF to generate monocyte-
derived macrophages (MDMs). In MoDC cultures, half
of the medium was replaced by fresh medium and
rhGM-CSF/rhIL-4 on days 2 and 4 of culture. In MDM
cultures, an additional 5 ng/ml rhGM-CSF was added
every 2 days and 10 ng/ml of lipopolysaccharide (LPS;
Invitrogen) was added for an additional 24 h of culture.
When indicated, 5 × 104 MSCs (MSC:monocyte ratio
1:10) were seeded in six-well flat-bottom culture plates,
monocytes were added the day after, and co-cultures
were performed as stated above.
Freshly isolated NK cells were cultured in 24-well flat-
bottom culture plates for 36 h in 50% DMEM/10% FCS
and 50% complete media supplemented with 10 ng/ml
rhIL-12 and 10 ng/ml rhIL-15 (MiltenyiBiotec). As a
negative control, NK cells were cultured in media alone.
MSC-NK cell co-cultures were performed at MSC:NK
cell ratios of 1:10 and 1:20, seeding MSCs the day before
and keeping a number of 3 × 104 MSCs.
For T-cell activation, enriched T-cell suspensions
(3 × 105) were cultured in 24-well flat-bottom culture
plates for 4 days with immobilized anti-human CD3
(HIT3a; 10 μg/ml) and soluble anti-human CD28
(CD28.2; 1 μg/ml) monoclonal antibodies (BioLegend).
As a negative control, T cell-enriched cells were cul-
tured in media alone. MSC-T cell co-cultures were per-
formed at a MSC:T cell-enriched ratio of 1:10, seeding
MSCs the day before.
Flow cytometry
See Additional file 1 (Table S1) for a list of antibodies
used. Immunofluorescence staining was performed as
described previously [10]. For intracellular staining, bre-
feldin A (BioLegend) was added for the final 4 h of cul-
ture and cells were treated with the Fixation/
Permeabilization Solution Kit (BD Biosciences). All flow
cytometry analyses were conducted in a FACSCalibur
flow cytometer (BD Biosciences) from the Centro de
Citometría y Microscopía de Fluorescencia, Complu-
tense University of Madrid, Spain.
Proliferation assays
Before culture, T lymphocyte-enriched cell suspensions
were labeled with 5 μM carboxyfluoroscein succinimi-
dyl ester (CFSE; BioLegend). Proliferation of T cells
(CD3+/CD4+ and CD3+/CD8+) was determined after
4 days by the CFSE dilution method. T cells were gated
according to forward and side scatter.
Apoptosis assays
The proportion of apoptotic MSCs was determined by in-
corporation of propidium iodide. MSC death was calcu-
lated as the percentage of CD90+/propidium iodide+ cells.
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Migration assays
MSCs (25 × 103) were seeded in 24-well flat-bottom cul-
ture plates. The next day, culture media with 10 ng/ml
rhIFN-gamma was added and 6.5-mm insert, 8.0-μm
polycarbonate membrane Transwell permeable supports
(Corning Life Sciences) were mounted. PBMCs (106)
were added into the inserts. Transwell cultures without
MSCs in the lower chamber were used as controls. Cells
were cultured for 14 h and migrated cells (present at the
lower chamber) were collected and stained for CD14.
The number of CD14+ cells were counted on a FACSCa-
libur flow cytometer and gated according to forward/side
scatter and lack of CD90 expression. Monocyte migra-
tion (MM) was calculated as follows:
MM ¼ N
 CD14þ cells with MSCsð Þ− N CD14þ cells without MSCsð Þ
N CD14þ cells without MSCs
 100
PCR analysis
RNA isolation was performed using the Absolutely RNA
Microprep kit (Stratagene Cloning Systems, Agilent
Technologies, Santa Clara, CA, USA), including DNase I
digestion. Total cDNA was synthesized by the High Cap-
acity cDNA Reverse Transcription Kit (Applied Biosys-
tems, Thermo Fisher Scientific). Taq-man assays
(Applied Biosystems) employed for real-time PCR are
shown in Additional file 1 (Table S2). All PCR reactions
were set in duplicates using the TaqMan Gene Expres-
sion Master Mix (Applied Biosystems). Amplifications,
detections, and analyses were performed in a 7.900HT
Fast Real-time PCR System (Centro de Genómica, Com-
plutense University, Madrid, Spain). The delta CT
method was used for normalization to GNB2L1 mRNA.
Cytokine measurements
Levels of IFN-gamma (R&D Systems), tumor necrosis
factor (TNF)-alpha and IL-10 in culture supernatants
were assayed by enzyme-linked immunosorbent assay
(ELISA; BioLegend). Production of CCL2/MCP-1 was
measured by cytometric bead array (CBA; BD
Biosciences).
Statistical analysis
Student t test was used for comparison of two sets of
data and one-way analysis of variance (ANOVA) for
multiple variables. Values of p ≤ 0.05 were considered to
be statistically significant.
Results
Efficient transduction of functionally active HIF-1 alpha in
dental MSCs
MSCs from dental pulp were expanded and transduced
with the lentiviral vectors pWP-GFP (GFP-MSCs) or
pWP-HIF-GFP (HIF-MSCs). Efficient transduction of
MSCs was confirmed by Western blot and qPCR, show-
ing increased levels of HIF-1 alpha protein and mRNA
in HIF-MSCs (Fig. 1a and b).
To investigate the impact of HIF-1 alpha overexpres-
sion on the metabolic state of MSCs, we performed
mitochondrial and glycolysis stress tests to compare the
OCR and glycolysis, respectively, between HIF-MSCs
with control GFP-MSCs. HIF-MSCs presented lower
basal respiration, ATP production, and maximal respir-
ation rates as assessed by injections of 1 μM oligomicin,
1 μM FCCP, and 1 μM antimycin A/rotenone (Fig. 1c
and d). Additionally, HIF-MSCs tended to show a higher
ECAR upon injection of 10 mM glucose (glycolysis) and
1 μM oigomycin (glycolytic capacity), indicating a
possible effect of HIF-1 alpha in enhancing glycolysis
(Additional file 1: Figure S1).
We further evaluated gene expression changes induced
by HIF-1 alpha by microarray analysis (Additional file 1:
Table S3). Gene Ontology analysis of genes upregulated
in HIF-MSCs versus GFP-MSCs revealed significant en-
richment of genes involved in biological processes asso-
ciated with hypoxia. Of note, similar results were
obtained when comparing hypoxia- versus normoxia-
cultured MSCs. These results indicate that overexpres-
sion of HIF-1 alpha recapitulates, at least in part,
transcriptional changes induced by hypoxia in MSCs.
Altogether, protein and mRNA levels and metabolic and
transcriptomic changes demonstrate that HIF-1 alpha is
functionally overexpressed in dental HIF-MSCs.
Effects of HIF-1 alpha overexpression in the modulation
of the adaptive immune response by dental MSCs
T cells and dendritic cells (DCs) are main players in
adaptive immunity, with T cells acting as main effectors
when a deleterious inflammatory response is developed.
In addition, impairment of the T-cell response is a well-
established feature of MSCs [11, 12]. As a first approach,
we investigated the impact of HIF-1 alpha expression on
the ability of MSCs to inhibit TCR-triggered activation
of T cells. When T cells were activated in the presence
of MSCs, proliferation of both CD4+ and CD8+ T cells
was dramatically reduced, regardless of HIF-1 alpha
overexpression by MSCs (Fig. 2a and b). As expected,
levels of IFN-gamma secreted by activated T cells were
severely reduced in the presence of both GFP-MSCs and
HIF-MSCs (Fig. 2c).
We next tested whether HIF-1 alpha overexpression
could improve the ability of MSCs to dampen DC differ-
entiation. Dental MSCs negatively affected the gener-
ation of CD14–CD1a+ MoDCs from monocytes.
Importantly, the inhibition of MoDC differentiation
showed a higher trend in HIF-MSC co-cultures, with a
constant reduction in the percentage of CD14–CD1a+
MoDCs observed in control co-cultures (Fig. 3a and b).
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Overexpression of HIF-1 alpha by MSCs potentiates
recruitment of monocytes which acquire
immunosuppressive properties
The generation of pro-inflammatory macrophages from
blood monocytes in response to environmental factors is
a key phenomenon in the development of inflammation
and tissue damage [13]. Our results show that the ma-
jority of monocytes cultured with both types of MSCs
exhibited a CD14high/CD163high phenotype (Fig. 4a and
b). This phenotype has been previously associated with
suppressor or M2 features in macrophages [14]. In line
with this, we found that the production of TNF-alpha
was severely impaired by the presence of both GFP-
MSCs and HIF-MSCs while IL-10 levels were remark-
ably increased in these co-cultures (Fig. 4c).
From a therapeutic point of view these results suggest
that the recruitment of monocytes to the site of inflam-
mation could be advantageous in patients transplanted
with dental MSCs. In this regard, CCL2/MCP-1 is the
main chemokine driving monocyte extravasation. We
found that HIF-MSCs exhibited augmented transcription
of CCL2/MCP-1 and that this difference was further en-
hanced in response to IFN-gamma (Fig. 4d). Coherently,
secretion of CCL2/MCP-1 was significantly higher in
IFN-gamma-stimulated HIF-MSCs (Fig. 4e), while basal
levels of this chemokine were hardly detected (data not
shown). Migration assays in the presence of IFN-gamma
showed that the higher production of CCL2/MCP-1 ob-
served in HIF-MSCs was accompanied by enhanced
migration of monocytes (Fig. 4f ).
HIF-1 alpha overexpression confers resistance to NK
cell-mediated lysis
Poor mid-term persistence of transplanted MSCs limits
the therapeutic impact of MSCs, most notably in myocar-
dial infarction cell therapy [15]. NK cells have been postu-
lated as key mediators in this process since they efficiently
lyse autologous and allogeneic MSCs, participating in the
clearance of these cells after transplantation, also accom-
panied by IFN-gamma secretion [16]. Consistent with the
literature, we found that degranulation of activated NK
cells was significantly increased in the presence of control
Fig. 1 Overexpression of HIF-1 alpha and mitochondrial stress test in MSCs. a Representative Western blot of hypoxia-inducible factor-1 (HIF-1)
alpha in mesenchymal stem cells (MSCs) and HIF-MSCs. Loading control was performed with tubulin and levels of HIF-1 alpha protein expression
were quantified by densitometry (right panel). b Expression of the HIF-1 alpha mRNA determined by quantitative PCR. GNB2L1 was used as
endogenous control. Date represent expression in HIF-MSCs relative to MSCs control (fold change; FC). Quantification of four independent
experiments; data are represented as mean ± SE (Student t test, *p ≤ 0.05). c Oxygen comsumption rate (OCR) response to oligomycin
(Oligo.; 1 μM), carbonyl cyanide p-trifluoromethoxy-phenylhydrazone (FCCP; 1 μM), and antimycin A/rotenone (Ant.A/Rot.; both 1 μM) injections.
HIF-MSCs (gray line) showed a lower OCR than MSCs (black line). d Mitochondrial substrate utilization in HIF-MSCs (gray) and MSCs (black)
measured in terms of basal respiration, ATP production, non-mitochondrial respiration, maximal respiration, proton leak, and spare respiratory
capacity. Data were normalized against the total amount of protein. Data are represented as mean ± SE of six independent experiments
(Student t test, *p≤ 0.05, **p≤ 0.01). GFP green fluorescent protein
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GFP-MSCs (Fig. 5a). Nevertheless, in HIF-MSC co-
cultures, increased NK cell degranulation was impaired. In
accordance with this, HIF-MSCs exhibited a marked re-
sistance to NK cell-mediated death (Fig. 5b). Also import-
antly, increased IFN-gamma production by NK cells was
strongly reduced by HIF-MSCs (Fig. 5c).
Interestingly, increased resistance of HIF-MSCs to
NK cell-mediated lysis was not associated with differen-
tial modulation of the NK cell effector molecules gran-
zyme B and perforin (Fig. 5d). Activation of the
receptors Natural Killer Group 2D (NKG2D) and
NKp30 has been shown to be critical for optimal lysis
of MSCs by activated NK cells [16]. Nevertheless, we
found no differences in the expression of NKG2D and
NKp30 between NK cells activated in the presence of
GFP-MSCs or HIF-MSCs (Fig. 5d). On the other hand,
analysis of the expression by MSCs of the ligands for
these NK cell-activating receptors revealed a reduction
in the basal expression of ULBP1 and B7H6 in HIF-
MSCs (Fig. 5e). These dissimilarities were strengthened
after stimulation with IFN-gamma, a pro-inflammatory
factor highly produced by activated NK cells, again with
a reduced expression of ULBP1, B7H6, and ULBP2 on
HIF-MSCs (Fig. 5f ).
Enhanced immunosuppressive and pro-angiogenic
features in HIF-1 alpha expressing MSCs
Next, we analyzed the expression of relevant factors
regulating inflammation and tissue remodeling.
Figure 6a represents the expression of immunomodula-
tory factors in control dental GFP-MSCs at basal levels
and after IFN-gamma stimulation. As shown in the
Fig. 2 HIF-1 alpha overexpression does not modify the ability of MSCs to inhibit T-cell activation. T cell-enriched peripheral blood cells were stained with
carboxyfluoroscein succinimidyl ester (CFSE) and activated with anti-CD3/anti-CD28 monoclonal antibodies in the presence or absence of mesenchymal
stem cells (MSCs; light grey) and hypoxia-inducible factor (HIF)-MSCs (dark grey). T cells (TC) were cultured in media alone as a negative control. After
4 days, expression of CD25 and proliferation of T-cell subsets was determined by flow cytometry. A representative experiment (a) and the mean ± SD of
three independent experiments (b) are shown. T cells were gated according to forward/side scatter characteristics and expression of CD3, CD4, and
CD8. c Supernatants of cultures were collected after 4 days and assayed for interferon (IFN)-gamma production. Data are presented as mean ± SD of
three independent experiments. One-way ANOVA, *p≤ 0.05, GFP-MSCs and HIF-MSCs versus no MSCs. GFP green fluorescent protein
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figure, IFN-gamma induced in GFP-MSCs the expression
of TLR3, TLR4, IL6, and, to a lesser extent, COX2. On the
contrary, LGALS1, encoding for galectin 1, was greatly
expressed by dental GFP-MSCs but not induced after
IFN-gamma stimulation (Fig. 6a). Comparative analysis
showed enhanced basal expression of the immunosup-
pressive molecules galectin 1 and IL-6 in HIF-MSCs
(Fig. 6b, left panel). In an inflammatory context, mimicked
by IFN-gamma stimulation, HIF-MSCs maintained a
higher expression of IL6 (Fig. 6b, right panel).
We also found that dental GFP-MSCs differentially
expressed a number of pro-angiogenic and trophic factors
of which only CXCL10 showed strong induction after IFN-
gamma treatment (Fig. 6c). Expression of CXCL12 and
CCL5 was higher in HIF-MSCs both at basal levels and
after the addition of IFN-gamma, while the basal transcrip-
tion of the pro-fibrotic factor TGFB1 was reduced (Fig. 6d,
left and right panels). Remarkably, overexpression of HIF-
1 alpha caused a complete loss of CXCL10 transcription in
HIF-MSCs under basal and inflammatory conditions.
Discussion
Dental MSC-based cell therapy is currently under exten-
sive research over a wide range of pathologies in which
inflammation plays a key role. These include wound
healing, spinal cord injury, and periodontitis [2, 17, 18].
While suppressor activities through T cell and macro-
phage responses have been previously described [19], the
role of dental MSCs cells in multiple immune interac-
tions remains elusive.
Our results show that inhibition of CD4+ and CD8+
T-cell responses to TCR stimulation by dental MSCs is
independent of HIF-1 alpha expression. This might be
correlated with the lack of differences in the expression
of COX2/PGE2, IL-10, and IDO (Fig. 5 and data not
shown), main factors driving T-cell inhibition by dental
MSCs [20, 21]. Recently, it was demonstrated that in-
hibition of the proliferation of PBMCs by gingival
MSCs is increased after hypoxia preconditioning, with
the participation of IL-10 and FasL [22]. Since total
PBMCs were used in these experiments, it is difficult to
know whether T cells were directly targeted by hypoxic
gingival MSCs. Accordingly, inhibition of T-cell prolif-
eration by adipose tissue-derived MSCs is not altered
under hypoxic conditions [23].
On the other hand, we found that HIF-1 alpha overex-
pression induces higher expression IL6, a known
negative regulator of DC differentiation and function
[24, 25]. Enhanced expression of IL6 has also been
shown in hypoxia-conditioned MSCs from bone marrow
[26]. This could explain that impairment of DC differen-
tiation by dental MSCs shows certain enhancement
when MSCs express HIF-1 alpha.
We also discovered that HIF-MSCs produce higher
levels of the chemokine CCL2/MCP1 under inflamma-
tory conditions, showing as well a tendency to promote
greater attraction of monocytes. This is in agreement
with recent data showing that conditioned medium
from hypoxic bone marrow-derived MSCs enhances
monocyte migration and recruitment of F4/80+ macro-
phages during wound healing [26]. Recent reports show
that dental MSCs induce suppressor macrophage differ-
entiation with the participation of different factors, in-
cluding IL-6 and CCL2/MCP-1 [18, 27]. Furthermore,
we present here that monocytes cultured with dental
MSCs exhibit high IL-10 and low TNF-alpha produc-
tion after LPS/TLR-4 stimulation. It is important to
note that TLR-4 agonists are normally present after
Fig. 3 Inhibition of dendritic cell differentiation by dental MSCs. Monocytes were differentiated towards dendritic cells with rhGM-CSF and rhIL-4
alone (Mo) or in the presence of control green fluorescent protein (GFP)-mesenchymal stem cells (MSCs; light grey) and hypoxia-inducible factor
(HIF)-MSCs (dark grey). After 7 days, cells were harvested, and the expression of CD14 and CD1a was analyzed by flow cytometry. A representative
experiment (a) and mean ± SD of four independent experiments (b) are shown. MSCs were excluded from the analysis by CD90 expression.
One-way ANOVA, *p ≤ 0.05, GFP-MSCs and HIF-MSCs versus no MSCs
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tissue damage [28]. Owing to the beneficial role nor-
mally attributed to anti-inflammatory macrophages
[29], we propose that expression of HIF-1 alpha by
MSCs would be advantageous for the resolution of in-
flammation through enhanced recruitment and differ-
entiation of suppressor macrophages.
NK cell-mediated lysis of MSCs might be linked to
the poor mid-term persistence of transplanted MSCs
observed in vivo [15, 16, 30]. Here, we confirm these
observations showing that NK cells are capable of kill-
ing dental MSCs, along with increased production of
IFN-gamma. Nevertheless, HIF-MSCs exhibit in-
creased resistance to NK cell-mediated lysis as shown
by reduced MSC cell death, NK cell degranulation, and
IFN-gamma production. Efficient NK cell-mediated
lysis requires binding of the activating receptors
Fig. 4 Monocyte differentiation and attraction in the presence of dental MSCs. Monocytes alone (Mo) or in the presence of green fluorescent protein
(GFP)-mesenchymal stem cells (MSCs; light grey) and hypoxia-inducible factor (HIF)-MSCs (dark grey) were cultured with rhGM-CSF to induce macrophage
differentiation. After 7 days, the expression of CD14 and CD163 was determined by flow cytometry. A representative experiment (a) and mean ± SD of
three independent experiments (b) are shown. MSCs were excluded from the analysis by CD90 expression. c After 7 days of culture, LPS was added for
24 h and supernatants were assayed for tumor necrosis factor (TNF) alpha and interleukin (IL)-10 production. Data are presented as mean ± SD of three
independent experiments. One-way ANOVA, *p≤ 0.05, GFP-MSCs and HIF-MSCs versus no MSCs. d, e MSCs were cultured until 80% confluence, then
fresh medium alone (Med) or medium supplemented with IFN-gamma (IFNγ) was added. After 15 h, cells and supernatants were harvested. Transcript
(d) and protein levels (e) for CCL2 were determined by quantitative PCR and CBA, respectively. GNB2L1 was used as endogenous control. Mean ± SD of
four samples pooled from two independent experiments is shown. Student t test, *p≤ 0.05, MSCs vs HIF-MSCs). f Transwell (8 μm) cultures were
performed as stated in the Methods section. After 14 h, migrated cells (present at the lower chamber) were collected and stained for CD14. MSCs were
excluded from the analysis by CD90 expression and monocytes were gated according to forward/side scatter characteristics and expression of CD14,
and counted in a FACSCalibur flow cytometer
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expressed on NK cells to their natural ligands,
expressed in MSCs [16]. Consistently, we show that
HIF-MSCs exhibit a significantly reduced expression of
the NK cell-activating receptor ligands ULBP1 and
B7H6 [31]. Interestingly, this mechanism is frequently
exploited by tumor cells [32–34]. These results are
coherent with the increased engraftment and survival
of hypoxia-conditioned MSCs after transplantation
[35, 36]. Considering that poor mid-term persistence
of transplanted MSCs is a limiting factor in the
therapeutic potential of MSCs [15], we here provide
evidence that supports HIF-1 alpha expression as a po-
tential useful approach to overcoming this limitation.
MSCs may exert tissue repair and regeneration
through paracrine factors, acting on surrounding cells
and directing cytoprotection and neovascularization [6].
We have found that HIF-MSCs exhibit enhanced expres-
sion of CXCL12/SDF1 and CCL5/RANTES, factors
widely known by their pro-angiogenic actions [37, 38].
Strikingly, our results demonstrate that HIF-1 alpha
Fig. 5 HIF-1 overexpression in MSCs confers resistance to NK cell-mediated lysis. Natural killer (NK) cells were cultured in media alone (black bars) or
with rhIL-12 and rhIL-15 in the absence (white bars) or presence of green fluorescent protein (GFP)-mesenchymal stem cells (MSCs; light grey) and
hypoxia-inducible factor (HIF)-MSCs (dark grey). After 36 h of culture, expression of CD107a (a), intracellular interferon (IFN)-gamma (c) and the indicated
molecules (d) was analyzed in NK cells by flow cytometry. MSCs were excluded from the analysis by CD90 expression. b MSC-NK cell co-cultures were
performed at the indicated MSC:NK cell ratios in presence of rhIL-12 and rhIL-15. After 36 h late apoptosis of MSCs was determined by CD90 expression
and propidium iodide (PI) incorporation. A representative experiment (b and c) and mean ± SD of three independent experiments (a and d) are
shown. One-way ANOVA, *p≤ 0.05, GFP-MSCs and HIF-MSCs versus no MSCs. e, f MSCs were cultured until 80% confluence was reached, and then
culture medium was replaced by fresh medium alone (e) or supplemented with IFN-gamma (f). After 15 h, cells were harvested and expression of the
indicated genes was determined by qPCR. GNB2L1 was used as endogenous control. Bars represent expression in HIF-MSCs relative to GFP-MSC
controls. Mean ± SD of six to eight samples pooled from at least three independent experiments is shown. Student t test, #p≤ 0.05, ##p≤ 0.005,
GFP-MSCs versus HIF-MSCs. IL interleukin
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expression in MSCs completely abrogates CXCL10/
IP10 expression. This factor can limit new vessel
growth by inhibiting endothelial cell migration, and
can induce involution of new vessels [39]. Similarly,
enhanced angiogenic potential of hypoxia-conditioned
MSCs has been shown in two different experimental
models for ischemia [35, 40].
Conclusions
Hypoxia preconditioning of MSCs significantly im-
proves the therapeutic effects of MSCs. Furthermore,
this procedure has been suggested for standardized
protocols of MSC preparation for clinical applications
[41]. The present work demonstrates that HIF-1 alpha
overexpression confers to MSCs enhanced paracrine
capacities which might participate in the previously de-
scribed benefits of HIF-MSC therapy after myocardial
infarction [7]. Furthermore, HIF-MSCs exhibit in-
creased resistance to NK cell-mediated lysis, which will
help to prolong their lifespan in the host. Although
further experiments using immunocompetent animals
are required to interrogate in vivo the mechanism de-
scribed in the present study, we believe that dental
MSCs and genetic engineering to express HIF-1 alpha
are powerful tools for furthering the therapeutic
potential of cell therapy.
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